glp 1 digestive issues The GLP-1 Era: Why These Intestinal Peptides Are Reshaping Modern Medicine GLP1 and GIP Receptor Agonists:

The Bigger Picture: Beyond Weight Loss GLP-1 medications represent a shift in how chronic metabolic diseases are treated

Reference: Henney, A

Together, these mechanisms reduce both the quantity of food you consume and the intensity of hunger cues your brain receives

With a growing number of patients using these medications for diabetes or to meet certain optimization goals before undergoing hip and knee reconstructive surgery, our aim was to establish evidence-based guidelines on when to discontinue these to enhance patient safety and surgical success. Study Data The study authors used the TriNetX Research Network, a multi-institutional national aggregated database, to identify patients who underwent TKA or THA between January 1, 2018, and January 1, 2023